Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 346.25
-10.50 (-2.94%)
Nov 6, 2026, 3:29 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 30.11 billion as of November 6, 2026. It is the 17,385th most valuable company in the world and the 1,059th biggest in India. Its market cap has increased by 263.10% in one year.
Market Cap
30.11B
Enterprise Value
26.47B
Revenue
7.64B
Global Rank
Country Rank
#1,059 India
PE Ratio
35.58
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 30.11B, an increase of 26,901.51%. That is a compound annual growth rate of 22.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 30.28B | 320.90% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 62.89B |
| Innova Captab | 58.56B |
| Orchid Pharma | 51.86B |
| RPG Life Sciences | 42.33B |
| Solara Active Pharma Sciences | 30.54B |
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |